Vimarsana
Biggest News Aggregation in the World

Alan Barge News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alan Barge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alan Barge Today - Breaking & Trending Today

ALL BLUE CAPITAL EXPANDS ITS LEADERSHIP TEAM TO SUPPORT PROPOSED ACQUISITION OF ZYMEWORKS INC. - Vimarsana News

ALL BLUE CAPITAL EXPANDS ITS LEADERSHIP TEAM TO SUPPORT PROPOSED ACQUISITION OF ZYMEWORKS INC.

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Zymeworks buyout bid backed by former AstraZeneca oncology head (NYSE:ZYME) - Vimarsana News

Zymeworks buyout bid backed by former AstraZeneca oncology head (NYSE:ZYME)

The investment firm All Blue Capital announced on Tuesday that Alan Barge, former head of Oncology at AstraZeneca (AZN), has agreed to advise the company in its recent proposal to...

Former AstraZeneca oncology head to help All Blue in Zymeworks takeover bid - Vimarsana News

Former AstraZeneca oncology head to help All Blue in Zymeworks takeover bid

(Reuters) - Investment firm All Blue Capital would be advised by Alan Barge, former oncology head at British drugmaker AstraZeneca Plc, in its bid to ...

Source: whbl.com
ALL BLUE CAPITAL ANNOUNCES LEADERSHIP TO SUPPORT PROPOSED ACQUISITION OF ZYMEWORKS, INC. - Vimarsana News

ALL BLUE CAPITAL ANNOUNCES LEADERSHIP TO SUPPORT PROPOSED ACQUISITION OF ZYMEWORKS, INC.

/PRNewswire/ -- All Blue Capital ("AB"), a global investment firm, today announced that biopharmaceutical industry leader and expert, Alan Barge, MD, has...

ALL BLUE CAPITAL ANNOUNCES LEADERSHIP TO SUPPORT PROPOSED ACQUISITION OF ZYMEWORKS, INC. - Vimarsana News

ALL BLUE CAPITAL ANNOUNCES LEADERSHIP TO SUPPORT PROPOSED ACQUISITION OF ZYMEWORKS, INC.

/PRNewswire/ -- All Blue Capital ("AB"), a global investment firm, today announced that biopharmaceutical industry leader and expert, Alan Barge, MD, has...